Literature DB >> 20376458

[Corneal melting in both eyes after simultaneous corneal cross-linking in a patient with keratoconus and Down syndrome].

C Faschinger1, R Kleinert, A Wedrich.   

Abstract

Corneal cross-linking is one of the options for treatment of progressive keratoconus. Following the published standards regarding indication and treatment schedules, it seems to be a highly safe and effective operation. Only a very few severe complications, such as stromal scarring and bacterial keratitis, have been reported.We describe a patient with keratoconus and Down syndrome who was treated with corneal cross-linking on both eyes simultaneously. One week after the operation he developed central corneal melting without signs of infection in his right eye, and 1 month after the operation in his left eye. Penetrating keratoplasties had to be performed on both eyes and were successful. A possible reason for the corneal melting might have been a corneal stroma that was thinner than the proposed limit of 400 µm at the centre. The published recommended standards should be met.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20376458     DOI: 10.1007/s00347-009-2127-6

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  19 in total

Review 1.  [Biophysical principles of collagen cross-linking].

Authors:  E Spörl; F Raiskup-Wolf; L E Pillunat
Journal:  Klin Monbl Augenheilkd       Date:  2008-02       Impact factor: 0.700

2.  [Corneal crosslinking: "Safe and effective"?].

Authors:  C Cursiefen
Journal:  Ophthalmologe       Date:  2009-02       Impact factor: 1.059

3.  Collagen crosslinking with ultraviolet-A and hypoosmolar riboflavin solution in thin corneas.

Authors:  Farhad Hafezi; Michael Mrochen; Hans Peter Iseli; Theo Seiler
Journal:  J Cataract Refract Surg       Date:  2009-04       Impact factor: 3.351

4.  Collagen crosslinking with riboflavin and ultraviolet-A light in keratoconus: long-term results.

Authors:  Frederik Raiskup-Wolf; Anne Hoyer; Eberhard Spoerl; Lutz E Pillunat
Journal:  J Cataract Refract Surg       Date:  2008-05       Impact factor: 3.351

Review 5.  Crosslinking treatment of progressive keratoconus: new hope.

Authors:  Gregor Wollensak
Journal:  Curr Opin Ophthalmol       Date:  2006-08       Impact factor: 3.761

6.  Stromal haze after combined riboflavin-UVA corneal collagen cross-linking in keratoconus: in vivo confocal microscopic evaluation.

Authors:  Cosimo Mazzotta; Angelo Balestrazzi; Stefano Baiocchi; Claudio Traversi; Aldo Caporossi
Journal:  Clin Exp Ophthalmol       Date:  2007-08       Impact factor: 4.207

7.  [Collagen crosslinking with riboflavin and UVA-light in keratoconus].

Authors:  M Kohlhaas
Journal:  Ophthalmologe       Date:  2008-08       Impact factor: 1.059

8.  [Corneal melting after cross-linking and deep lamellar keratoplasty in a keratoconus patient].

Authors:  P Eberwein; C Auw-Hädrich; F Birnbaum; P C Maier; T Reinhard
Journal:  Klin Monbl Augenheilkd       Date:  2008-01       Impact factor: 0.700

9.  [Collagen cross-linking with riboflavin and UVA light in keratoconus. Results from Dresden].

Authors:  A Hoyer; F Raiskup-Wolf; E Spörl; L E Pillunat
Journal:  Ophthalmologe       Date:  2009-02       Impact factor: 1.059

10.  Keratocyte apoptosis after corneal collagen cross-linking using riboflavin/UVA treatment.

Authors:  Gregor Wollensak; Eberhard Spoerl; Michaela Wilsch; Theo Seiler
Journal:  Cornea       Date:  2004-01       Impact factor: 2.651

View more
  12 in total

Review 1.  [Complications of corneal cross-linking].

Authors:  T G Seiler; G Schmidinger; I Fischinger; T Koller; T Seiler
Journal:  Ophthalmologe       Date:  2013-07       Impact factor: 1.059

2.  Corneal Perforation After Corneal Cross-Linking in Keratoconus Associated With Potentially Pathogenic ZNF469 Mutations.

Authors:  Wenlin Zhang; J Ben Margines; Deborah S Jacobs; Yaron S Rabinowitz; Evelyn Maryam Hanser; Tulika Chauhan; Doug Chung; Yelena Bykhovskaya; Ronald N Gaster; Anthony J Aldave
Journal:  Cornea       Date:  2019-08       Impact factor: 2.651

3.  A short-term study of corneal collagen cross-linking with hypo-osmolar riboflavin solution in keratoconic corneas.

Authors:  Shao-Feng Gu; Zhao-Shan Fan; Li-Hua Wang; Xiang-Chen Tao; Yong Zhang; Chun-Qin Wang; Ya Wang; Guo-Ying Mu
Journal:  Int J Ophthalmol       Date:  2015-02-18       Impact factor: 1.779

4.  [Corneal cross-linking with hypo-osmolar riboflavin solution for keratoconus with thin corneas].

Authors:  F Raiskup; A Kissner; E Spoerl; L E Pillunat
Journal:  Ophthalmologe       Date:  2011-09       Impact factor: 1.059

Review 5.  Adverse events after riboflavin/UV-A corneal cross-linking: a literature review.

Authors:  Sebastiano Serrao; Giuseppe Lombardo; Marco Lombardo
Journal:  Int Ophthalmol       Date:  2021-08-27       Impact factor: 2.031

6.  Corneal Collagen Cross-linking for Treatment of Bacterial and Herpetic Keratitis.

Authors:  Mohammad Reza Khalili; Hamid Reza Jahadi; Mashaallah Karimi; Masoud Yasemi
Journal:  J Clin Diagn Res       Date:  2017-07-01

7.  Corneal melting after collagen cross-linking for keratoconus: a case report.

Authors:  Georgios Labiris; Eleni Kaloghianni; Stavrenia Koukoula; Athanassios Zissimopoulos; Vassilios P Kozobolis
Journal:  J Med Case Rep       Date:  2011-04-16

8.  Infectious keratitis after corneal crosslinking: systematic review.

Authors:  Caroline E Murchison; W Matthew Petroll; Danielle M Robertson
Journal:  J Cataract Refract Surg       Date:  2021-08-01       Impact factor: 3.528

9.  Performing corneal crosslinking under local anaesthesia in patients with Down syndrome.

Authors:  Nienke Soeters; Esmée Bennen; Robert P L Wisse
Journal:  Int Ophthalmol       Date:  2017-04-19       Impact factor: 2.031

10.  Corneal Melting after Collagen Cross-Linking for Keratoconus in a Thin Cornea of a Diabetic Patient Treated with Topical Nepafenac: A Case Report with a Literature Review.

Authors:  Karim Mohamed-Noriega; Karla Butrón-Valdez; Jeronimo Vazquez-Galvan; Jibran Mohamed-Noriega; Humberto Cavazos-Adame; Jesús Mohamed-Hamsho
Journal:  Case Rep Ophthalmol       Date:  2016-02-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.